X2S Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Sinopharm Group Co Ltd

Watchlist Manager

Watchlist

Price: 1.8125 EUR 2.84% Market Closed

Market Cap: €5.7B

S	Sinopharm Group Co Ltd SWB:X2S	CN
B	Belden Inc F:QCTA	US
P	Persimmon PLC XBER:OHP	UK
A	Aramark F:0AK	US
	Capitec Bank Holdings Ltd OTC:CKHGF	ZA
M	Muenchener Rueckversicherungs Gesellschaft in Muenchen AG OTC:MURGF	DE
	Sandvik AB OTC:SDVKF	SE
	RH F:RS1	US
	Vodacom Group Ltd OTC:VDMCY	ZA

Profitability Summary

Sinopharm Group Co Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Declining Gross Margin

8% > 7%

Low Operating Margin

Low 3Y Average Operating Margin

Declining Operating Margin

4% > 3%

Low Net Margin

Low 3Y Average Net Margin

Declining Net Margin

2% > 1%

Healthy Free Cash Flow Margin

Sustainable 3Y Average Free Cash Flow Margin

Free Cash Flow Margin is Increasing

2% > 2%

Low ROE

Positive 3Y Average ROE

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.